Helmerich & Payne target price raised to $51 from $50
HP•Barclays raised its target price for Helmerich & Payne to $51 from $50.
Related News
Appian Corp: Barclays raises target price to $30 from $26
APPN•
DataMeds AI unit Helomics wins Humana Medicaid coverage for ChemoFx gynecologic cancer assay
MEDS•
Gravis sees data center capacity doubling to 200GW by 2030 as occupancy runs at 97%
XLRE•
Zebra Technologies: Citigroup raises target price to $400 from $396
ZBRA•
Needham cuts Enovis target price to $34 from $52
ENOV•